Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500100520Phase 4Not yet recruiting
Phase 4, open-label trial of oliceridine in Micturition disorder (3 arms), sponsored by The Second Hospital of Jilin University. Primary endpoints: NRS score and Incidence of moderate to severe urinary tract irritation. Planned start Apr 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500100520.